Compare SYBT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYBT | BHVN |
|---|---|---|
| Founded | 1904 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2009 | 2022 |
| Metric | SYBT | BHVN |
|---|---|---|
| Price | $78.37 | $15.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $76.00 | $29.08 |
| AVG Volume (30 Days) | 113.1K | ★ 2.9M |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | 22.11 | ★ 26.08 |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $23,406,000.00 | N/A |
| Revenue This Year | $17.31 | N/A |
| Revenue Next Year | $9.32 | N/A |
| P/E Ratio | $31.06 | ★ N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $61.51 | $7.48 |
| 52 Week High | $89.22 | $18.57 |
| Indicator | SYBT | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 57.49 |
| Support Level | $77.35 | $8.84 |
| Resistance Level | $78.73 | $17.01 |
| Average True Range (ATR) | 1.79 | 1.20 |
| MACD | -0.74 | 0.18 |
| Stochastic Oscillator | 7.91 | 55.53 |
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.